🎉 M&A multiples are live!
Check it out!

Sensorion Valuation Multiples

Discover revenue and EBITDA valuation multiples for Sensorion and similar public comparables like Pharming, Galapagos, and Benevolent AI.

Sensorion Overview

About Sensorion

Sensorion SA is a France-based clinical-stage biotech company dedicated to developing therapies to restore, treat, and prevent hearing loss. The company's product is in phase 2a clinical development, SENS-401 (Arazasetron) in Sudden Sensorineural Hearing Loss (SSNHL). SENS-401 is being developed to treat cochlear pathologies. The Company does business in a single operating segment: conducting research and development to discover drugs to treat inner ear disorders with a view to their future marketing. The company's pipeline programs are SENS-401 SSNHL, SENS-401 CIO, GJB2-GT, GJB2-GT, SENS-401 Cochlear, and others.


Founded

2010

HQ

France
Employees

65

Website

sensorion.com

Financials

LTM Revenue $9.8M

LTM EBITDA -$37.7M

EV

$16.8M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Sensorion Financials

Sensorion has a last 12-month revenue of $9.8M and a last 12-month EBITDA of -$37.7M.

In the most recent fiscal year, Sensorion achieved revenue of n/a and an EBITDA of -$27.3M.

Sensorion expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Sensorion valuation multiples based on analyst estimates

Sensorion P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $5.1M n/a XXX XXX XXX
Gross Profit n/a n/a XXX XXX XXX
Gross Margin NaN% NaN% XXX XXX XXX
EBITDA -$22.9M -$27.3M XXX XXX XXX
EBITDA Margin -450% -Infinity% XXX XXX XXX
Net Profit -$24.9M -$23.7M XXX XXX XXX
Net Margin -489% -Infinity% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Sensorion Stock Performance

As of April 15, 2025, Sensorion's stock price is EUR 0 (or $0).

Sensorion has current market cap of EUR 90.5M (or $97.2M), and EV of EUR 15.7M (or $16.8M).

See Sensorion trading valuation data

Sensorion Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$16.8M $97.2M XXX XXX XXX XXX $-0.09

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Sensorion Valuation Multiples

As of April 15, 2025, Sensorion has market cap of $97.2M and EV of $16.8M.

Sensorion's trades at 1.7x LTM EV/Revenue multiple, and -0.4x LTM EBITDA.

Analysts estimate Sensorion's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Sensorion and 10K+ public comps

Sensorion Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $16.8M XXX XXX XXX
EV/Revenue n/a XXX XXX XXX
EV/EBITDA -0.6x XXX XXX XXX
P/E -3.5x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -0.7x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Sensorion Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Sensorion Valuation Multiples

Sensorion's NTM/LTM revenue growth is 74%

Sensorion's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged $0.5M for the same period.

Over next 12 months, Sensorion's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Sensorion's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Sensorion and other 10K+ public comps

Sensorion Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -100% XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth 19% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee n/a XXX XXX XXX XXX
Opex per Employee $0.5M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue n/a XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Sensorion Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Sensorion M&A and Investment Activity

Sensorion acquired  XXX companies to date.

Last acquisition by Sensorion was  XXXXXXXX, XXXXX XXXXX XXXXXX . Sensorion acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Sensorion

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Sensorion

When was Sensorion founded? Sensorion was founded in 2010.
Where is Sensorion headquartered? Sensorion is headquartered in France.
How many employees does Sensorion have? As of today, Sensorion has 65 employees.
Who is the CEO of Sensorion? Sensorion's CEO is Ms. Nawal Ouzren.
Is Sensorion publicy listed? Yes, Sensorion is a public company listed on PAR.
What is the stock symbol of Sensorion? Sensorion trades under ALSEN ticker.
When did Sensorion go public? Sensorion went public in 2015.
Who are competitors of Sensorion? Similar companies to Sensorion include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Sensorion? Sensorion's current market cap is $97.2M
What is the current revenue of Sensorion? Sensorion's last 12-month revenue is $9.8M.
What is the current EBITDA of Sensorion? Sensorion's last 12-month EBITDA is -$37.7M.
What is the current EV/Revenue multiple of Sensorion? Current revenue multiple of Sensorion is 1.7x.
What is the current EV/EBITDA multiple of Sensorion? Current EBITDA multiple of Sensorion is -0.4x.
Is Sensorion profitable? Yes, Sensorion is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.